Dextromethorphan and Silymarin in Chronic Kidney Disease (CKD) Patients
Status:
Unknown status
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The investigators test the renal and cardiovascular protective effects dextromethorphan and
silymarin on patients with the proteinuric chronic kidney diseases, who enrolled in our
clinical trial, had progressing kidney diseases and merit aggressive anti-inflammatory
therapy.